Apellis Pharmaceuticals (APLS)
(Delayed Data from NSDQ)
$49.86 USD
+1.93 (4.03%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $49.83 -0.03 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/7/24 |
---|---|
Current Quarter | -0.55 |
EPS Last Quarter | -0.73 |
Last EPS Surprise | -10.61% |
ABR | 1.44 |
Earnings ESP
|
-12.82% |
---|---|
Current Year | -1.34 |
Next Year | 1.07 |
EPS (TTM) | -4.48 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 158.06M | 186.72M | 785.66M | 1.17B |
# of Estimates | 8 | 8 | 8 | 8 |
High Estimate | 178.58M | 228.28M | 919.78M | 1.26B |
Low Estimate | 137.45M | 171.13M | 719.23M | 1.04B |
Year ago Sales | 44.85M | 94.97M | 396.59M | 785.66M |
Year over Year Growth Est. | 252.42% | 96.60% | 98.10% | 48.97% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.55 | -0.39 | -1.34 | 1.07 |
# of Estimates | 10 | 8 | 10 | 10 |
Most Recent Consensus | -0.83 | -0.49 | -2.18 | 1.05 |
High Estimate | -0.28 | 0.09 | 0.46 | 2.28 |
Low Estimate | -0.83 | -0.60 | -2.18 | 0.07 |
Year ago EPS | -1.56 | -1.02 | -4.45 | -1.34 |
Year over Year Growth Est. | 64.74% | 61.76% | 69.89% | 179.85% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 1 | 2 | 0 |
Up Last 60 Days | 2 | 3 | 5 | 2 |
Down Last 7 Days | 1 | 1 | 1 | 2 |
Down Last 30 Days | 2 | 1 | 1 | 4 |
Down Last 60 Days | 6 | 5 | 5 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.55 | -0.39 | -1.34 | 1.07 |
7 Days Ago | -0.55 | -0.39 | -1.33 | 1.08 |
30 Days Ago | -0.53 | -0.39 | -1.36 | 1.09 |
60 Days Ago | -0.46 | -0.30 | -1.10 | 1.25 |
90 Days Ago | -0.55 | -0.40 | -1.38 | 0.95 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.63 | -0.33 | -1.48 | 1.22 |
Zacks Consensus Estimate | -0.55 | -0.39 | -1.34 | 1.07 |
Earnings ESP | -12.82% | 15.92% | -10.37% | 13.66% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.73 | -1.17 | -1.02 | -1.56 | NA |
Estimate | -0.66 | -0.84 | -1.35 | -1.42 | NA |
Difference | -0.07 | -0.33 | 0.33 | -0.14 | -0.05 |
Surprise | -10.61% | -39.29% | 24.44% | -9.86% | -8.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more